Results 161 to 170 of about 679,715 (383)

Ames collaborative study of cosmic ray neutrons [PDF]

open access: yes
The results of a collaborative study to define both the neutron flux and the spectrum more precisely and to develop a dosimetry package that can be flown quickly to altitude for solar flare events are described.
Baum, J. W.   +9 more
core   +1 more source

Unleashing the Potential of Defect Engineered Persistent Pr3+‐Activated Phosphors for Multi‐Dimensional Anti‐Counterfeiting and X‐Ray Imaging Applications

open access: yesSmall, EarlyView.
Enhanced multicolor persistent luminescence with optimized trap depths (≈0.73 eV) in Ca3Ga2Ge3O12:Pr3+ phosphors enable advanced anti‐counterfeiting, optical storage, and high‐resolution X‐ray imaging (4 lp mm−1), surpassing commercial screens.
Annu Balhara   +8 more
wiley   +1 more source

Measurement of Low 14C Activities in a Liquid Scintillation Counter in the Zagreb Radiocarbon Laboratory

open access: yesRadiocarbon: An International Journal of Cosmogenic Isotope Research, 2004
N. Horvatinčič   +3 more
semanticscholar   +1 more source

Tumor‐Targeted Radioiodinated Glyconanoparticles for Doxorubicin Delivery and Auger‐Chemotherapy in Triple‐Negative Breast Cancer

open access: yesSmall, EarlyView.
Combining multiple anti‐tumor therapeutic modalities using nanoparticles allows harnessing their therapeutic potential in combination with minimal side effects at lower doses. This study focuses on the development of tumor‐responsive core‐shell glyconanoparticle formulation targeting galectin‐3 in triple‐negative breast cancer (TNBC) for Auger ...
Shishu Kant Suman   +3 more
wiley   +1 more source

The Secondary Scintillation Output of Xenon in a Uniform Field Gas Proportional Scintillation Counter

open access: yesIEEE Transactions on Nuclear Science, 1977
C. A. N. Conde   +2 more
semanticscholar   +1 more source

Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants. [PDF]

open access: yesBr J Clin Pharmacol
Abstract Aims Paltusotine is a novel, nonpeptide, selective somatostatin receptor 2 agonist in development for the treatment of acromegaly and carcinoid syndrome. This study investigated the mass balance, routes of excretion, absolute bioavailability and metabolite profile of orally administered paltusotine.
Luo R   +6 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy